Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention.

Immunology and cell biology - 1 Aug 2005

Xu Yanfei, Sette Alessandro, Sidney John, Gendler Sandra J, Franco Alessandra

Abstract excerpt

Here we examine the use of glycopeptides containing tumour-associated carbohydrate antigens (TACA) as potential preventive vaccines for carcinomas. Our recent results suggest that CD8+ T cells (CTL) are capable of recognizing TACA in a conventional class I MHC-restricted fashion. The ThomsenFriedenreich antigen (TF), a disaccharide, and Tn, its immediate precursor, are TACA largely expressed in carcinomas. TF and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Tumor-Associated, Carbohydrate
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycopeptides

Share to Histocompatibility Antigens Class I

Share to Mice, Transgenic

Share to Mucin-1

Share to T-Lymphocytes, Cytotoxic

Share to Vaccination

Source

Identifiers

PMID: 16033540
DOI: 10.1111/j.1440-1711.2005.01347.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention.PMID 16033540Read ↗

Tumor-associated carbohydrate antigens of MUC1 – Implication in cancer developmentSemantic proximity Read ↗

Genetically modified immune cells targeting tumor antigensSemantic proximity Read ↗

Recognition of tumor-associated antigens by T lymphocytes: from basic concepts to new approaches.Semantic proximity Read ↗

Vaccination with T cell-defined antigens.Semantic proximity Read ↗

Identification of tumour-associated T-cell epitopes for vaccine development.Semantic proximity Read ↗

Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.Semantic proximity Read ↗

CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.Semantic proximity Read ↗

Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccinesSemantic proximity Read ↗

Germline-encoded recognition of diverse glycolipids by natural killer T cellsSemantic proximity Read ↗

[Tumor antigens presented to T helper lymphocytes--critical components of the cancer vaccine].Semantic proximity Read ↗

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.Semantic proximity Read ↗

The viral vectored vaccine targeting Thymosin β10 controls tumour growth in a murine model of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.